Atlas Trials

A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

Clinical trial NCT06588153 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06588153
Sponsor
Amgen
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Glucocorticoid-induced Osteoporosis
Start date
2025-05-24
Primary completion
2027-04-27
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.